FMC

FMC Corporation Q1 2006 Filing Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended March 31, 2006. FMC Corporation is a diversified, global chemical company operating in three segments: Agricultural Products, Specialty Chemicals, and Industrial Chemicals. The company reported strong first-quarter performance across all businesses, with consolidated revenue increasing 8% year-over-year.

Key Financial Metrics

Material Changes vs. Prior Period

• Net Income Decline: Net income decreased significantly from $64.5 million to $37.7 million. This was primarily driven by a $29.0 million gain from discontinued operations in Q1 2005 (sale of San Jose real estate) that did not recur, and a new $30 million fine recorded in Q1 2006.
• European Commission Fine: The company recorded a $30 million charge (€25 million) in "Restructuring and other charges" related to an antitrust fine imposed by the European Commission regarding hydrogen peroxide business violations prior to 2000. The company intends to appeal.
• Segment Performance:
  • Agricultural Products: Revenue up 4% to $206.6 million; Operating profit up 63% to $54.7 million.
  • Specialty Chemicals: Revenue up 5% to $143.2 million; Operating profit up 11% to $31.5 million.
  • Industrial Chemicals: Revenue up 12% to $245.2 million; Operating profit up 35% to $29.2 million (before the $30M fine).
• Interest Expense: Net interest expense decreased to $8.4 million from $17.0 million due to lower debt levels and interest costs.
• Accounting Changes: The company adopted SFAS 123R (Share-Based Payment) on January 1, 2006, recognizing $1.5 million in share-based compensation expense.

Guidance, Outlook, and Risks

• Dividends and Buybacks: The Board initiated a quarterly cash dividend of $0.18 per share and authorized a $150 million stock repurchase program. No shares were repurchased in Q1 2006.
• Future Restructuring: The company announced a plan to redeploy R&D resources in the Agricultural Products segment, expecting to incur an additional $5 million to $8 million in restructuring charges in Q2 2006.
• Asset Sales: The company expects to close the sale of remaining San Jose property (approx. 23 acres) by the end of Q2 2006 for approximately $25 million, recording a gain in discontinued operations. An agreement to sell the FMC Research Center in Princeton, NJ, was signed in May 2006, with closing expected in 2007.
• Legal and Environmental Risks:
  • Antitrust: Ongoing investigations and class actions regarding hydrogen peroxide and microcrystalline cellulose in the U.S. and Canada.
  • Environmental: Total environmental reserves are $163.4 million. The company estimates reasonably possible contingent losses may exceed accrued amounts by up to $85.0 million.
  • Appeal: The $30 million European fine is classified as a long-term liability pending appeal.
• Outlook: Management expects full-year 2006 earnings growth in the mid-teens for Agricultural Products, mid-single digits for Specialty Chemicals, and 40-45% for Industrial Chemicals (excluding the impact of the fine and Astaris divestiture).

Investor Verification Checklist

• Verify the status of the appeal regarding the $30 million European Commission fine and potential additional penalties.
• Monitor the timeline and final terms of the San Jose property sale and the Princeton Research Center sale.
• Review the impact of the $5-8 million R&D restructuring charges expected in Q2 2006.
• Assess the progress of ongoing antitrust litigation in the U.S. and Canada regarding hydrogen peroxide.
• Track the execution of the $150 million stock repurchase program and dividend sustainability.
• Confirm the company's ability to meet environmental spending projections of approximately $56.7 million in 2006.